Vimarsana
Biggest News Aggregation in the World

Page 13 - Scientist Training Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientist Training Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientist Training Program Today - Breaking & Trending Today

Genes indicating risk for Alzheimer's identified using novel testing methods - Vimarsana News

Genes indicating risk for Alzheimer's identified using novel testing methods

A new UCLA-led study used a combination of new testing methods to identify multiple new risk genes for Alzheimer disease and a rare, related brain disorder ca

New Blood Test Can Detect 'Toxic' Protein Years Before Alzheimer's Symptoms Emerge - Vimarsana News

New Blood Test Can Detect 'Toxic' Protein Years Before Alzheimer's Symptoms Emerge

A new blood test can detect toxic amyloid beta oligomers associated with Alzheimer's disease years before symptoms appear.

Role Reversal - Vimarsana News

Role Reversal

In this narrative essay, a medical student discusses how observing a patient interacting with her adult daughter was a reminder of the ways in which the roles

Six U-M researchers receive Biosciences Initiative award for excellence among mid-career faculty - Vimarsana News

Six U-M researchers receive Biosciences Initiative award for excellence among mid-career faculty

Six University of Michigan scientists and engineers have been named the 2022 winners of the MBioFAR Award, which recognizes exceptional mid-career faculty in the biosciences. MBioFAR, which stands for Mid-career Biosciences Faculty Achievement Recognition, is an annual award established last year

Source: umich.edu
Prostate cancer genetic test an effective tool for estimating disease risk - Vimarsana News

Prostate cancer genetic test an effective tool for estimating disease risk

Their genetic test involved screening for 290 genetic variants and could provide doctors an extra tool for estimating a person’s risk for prostate cancer.